Virology Journal2009Open Access
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuanyuan Zhang, En‐Qiang Chen, Jin Yang et al.
41 citations2009Open Access — see publisher for license terms1 related compound
Research Article — Peer-Reviewed Source
Original research published by Zhang et al. in Virology Journal. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Abstract
Among HBeAg-positive patients, thymosin alpha-1 and lamivudine combination therapy may be more effective than lamivudine monotherapy, providing superior rates of biochemical response, virological response, and HBeAg seroconversion.
Full Text
Full text is available at the publisher.
Read at PublisherArticle Details
| DOI | 10.1186/1743-422x-6-63 |
| Journal | Virology Journal |
| Year | 2009 |
| Authors | Yuanyuan Zhang, En‐Qiang Chen, Jin Yang, Yu-Rong Duan, Hong Tang |
| License | Open Access — see publisher for license terms |
| Citations | 41 |